C-MER Medical Holdings repurchases shares, boosting treasury

C-MER Medical Holdings Limited (03309) submitted a Next Day Disclosure Return on December 2, 2025, detailing changes in its issued shares and treasury shares. The company repurchased 160,000 ordinary shares on December 2, 2025, at prices ranging from HK$1.75 to HK$1.76 per share, totaling an aggregate price of HK$280,080. These repurchased shares are being held as treasury shares.

Following this transaction, the number of issued shares (excluding treasury shares) decreased by 160,000 to 1,237,480,870 shares, while the number of treasury shares increased by 160,000 to 18,080,000 shares. The total number of issued shares remains unchanged at 1,255,560,870. The repurchase represents 0.0129% of the existing number of issued shares (excluding treasury shares) prior to the event.

The company also disclosed numerous past share repurchases for cancellation, dating from July 2024 through May 2025, but these shares have not yet been cancelled as of the closing balance date. The repurchase mandate, authorizing up to 125,556,087 shares, was granted on May 19, 2025. The moratorium period for any issue of new shares or sale/transfer of treasury shares after the repurchase extends up to January 1, 2026.